By delivering gene therapies to patients before they go blind, doctors may be able to prevent the loss of many important light-detecting cells.
Susan YoungFollow @twitterapi
I’m the biomedicine editor for MIT Technology Review. I look for stories where technology stands to improve human health or advance our understanding of the human condition.
I joined MIT Technology Review in March 2012 after a brief stint in the Washington, D.C., news bureau of the scientific journal Nature. Before I ventured to the East Coast, I spent several years in the San Francisco Bay Area as a doctoral student in molecular biology and one whirlwind year in science-writing boot camp in Santa Cruz.
In California, I wrote for the Stanford University press offices, the Multiple Sclerosis Discovery Forum, and the Salinas Californian newspaper. I grew up in a small town in eastern Texas, surrounded by bird song, rolling cattle fields, and lanky pine trees. When I’m not exploring health tech, you will probably find me cooking or giggling over an exceptional LOLcat.
Susan Young's Stories
Illumina announces a new high-end sequencer made for “factory-scale” sequencing of human genomes.
A former hockey player founded a company to give athletes and families a better way to identify brain injuries.
New method could help scientists understand neural circuits and tumor biology.
Following the Supreme Court's rejection of gene patents, the U.S. proposes steep cuts to reimbursements for tests that detect breast cancer genes.
A push for new brain-mapping technology and a ban on some gene patents showcase ongoing advances in biomedical technology.
New cardiac devices are small enough to be delivered through blood vessels into the heart.
Using chemical reactions to synthesize complex protein drugs could help researchers create more effective medicines.
IBM researchers have developed a new polymer-like material to treat fungal infections.
Personal genetics company 23andMe will only sell ancestry reports and raw data as controversy with regulators continues.